President Donald Trump is reportedly planning to sign a new executive order that will increase research into psychedelic drugs used to treat mental illnesses, potentially paving the way for their legal use in controlled environments.
The commander in chief is in talks to draft the order, which would release new guidance for medical research on drugs such as psilocybin and ibogaine, multiple insiders told The Washington Post.
While speaking to reporters aboard Air Force One on Friday, Trump teased an upcoming announcement scheduled for Saturday morning on something he feels ‘strongly about.’
The president called the impending revelation a ‘very positive thing,’ adding that he would be joined by a ‘very good, very smart, very caring’ person to make the official announcement.
Trump ‘to sign executive order’ that will ease access to psychedelic drug used to treat PTSD
American Buddhist Net 